SURMOUNT-2 Trial Deep Dive | The Obesity Podcast Ep.2: Journal Club | J&J MedTech

Подробнее о видео

Approved Market: EMEA

Join Prof. Marco Bueter, Dr. Imane Eddbali, MD, and guest expert Prof. Carel Le Roux on The Obesity Podcast's Journal Club Series. In this new episode, they discuss the impactful findings of the SURMOUNT-2 trial and its implications for obesity management. Click here to explore our bariatric surgery resources ►

Listen to the other episodes here ►

More Bariatric Surgery videos here ►

Subscribe to J&J MedTech and stay tuned for the latest innovations in surgical procedures and medical devices:

Follow us on X at
Follow us on LinkedIn at

To view additional on-demand online learning resources, visit
Follow J&J Institute on LinkedIn at
Follow J&J Institute on X at

#JnJMedTech #Obesity #BariatricSurgery
In the second episode of the Obesity Podcast, Prof. Marco Bueter and Dr. Imane Eddbali discuss the SURMOUNT-2 trial ("Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes") with Prof. Carel Le Roux.
EM_ETH_ALLE_393836